KFA Private Wealth Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$542K Sell
452
-27
-6% -$27.6K 0.13% 73
2026
Q1
$441K Hold
479
0.11% 93
2025
Q4
$515K Buy
479
+105
+28% +$100K 0.13% 79
2025
Q3
$286K Buy
374
+2
+0.5% +$1.49K 0.08% 112
2025
Q2
$290K Sell
372
-10
-3% -$7.77K 0.09% 106
2025
Q1
$316K Buy
382
+25
+7% +$20.8K 0.11% 80
2024
Q4
$275K Buy
357
+13
+4% +$10.8K 0.12% 73
2024
Q3
$305K Sell
344
-1
-0.3% -$899 0.15% 62
2024
Q2
$312K Buy
345
+69
+25% +$55.2K 0.16% 61
2024
Q1
$215K Buy
+276
New +$196K 0.07% 97

Other funds holding LLY

KFA Private Wealth Group's LLY Position: Q2 2026 in Review

KFA Private Wealth Group reduced its Eli Lilly (LLY) stake by 5.6% in Q2 2026, selling an estimated $27.6K and leaving 452 shares worth $542K. The position accounts for 0.13% of the portfolio, ranked #73.

KFA Private Wealth Group first reported a position in LLY in Q1 2024 and has held it in 10 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • KFA Private Wealth Group held 452 shares of Eli Lilly worth $542K as of Q2 2026.
  • KFA Private Wealth Group sold 27 Eli Lilly shares in Q2 2026, an estimated $27.6K.
  • Eli Lilly made up 0.13% of KFA Private Wealth Group's portfolio in Q2 2026, its #73 holding.
  • KFA Private Wealth Group first reported a position in Eli Lilly in Q1 2024 and has held it in 10 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on KFA Private Wealth Group's 13F filing for Q2 2026, filed 28 Jul 2026.